Verve Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is July - June.

Millions USD. Fiscal year is Jul - Jun.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2016 - 2020
Period Ending	Aug '25 Aug 6, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2016 - 2020
Market Capitalization	193	24	1	1	1	2	Upgrade
Market Cap Growth	-30.00%	3023.72%	-28.28%	6.00%	-39.13%	-54.90%	Upgrade
Enterprise Value	198	29	1	1	1	2	Upgrade
Last Close Price	1.19	0.15	0.53	0.74	0.70	1.15	Upgrade
PS Ratio	131.42	11.62	1.22	-	-	-	Upgrade
PB Ratio	-112.64	-43.33	2.83	-4.87	-5.47	-39.03	Upgrade
P/TBV Ratio	-	-	2.85	-	-	-	Upgrade
EV/Sales Ratio	135.39	13.96	1.61	-	-	-	Upgrade
Debt / Equity Ratio	-3.42	-9.19	9.55	-0.93	-	-	Upgrade
Asset Turnover	0.32	0.52	-	-	-	-	Upgrade
Inventory Turnover	8.41	5.02	-	-	-	-	Upgrade
Quick Ratio	0.01	0.03	0.10	-	-	-	Upgrade
Current Ratio	0.10	0.24	0.28	-	-	-	Upgrade
Return on Assets (ROA)	-12.67%	-11.28%	-	-	-	-	Upgrade
Return on Capital (ROIC)	-13.61%	-12.00%	-	-	-	-	Upgrade
Earnings Yield	-0.54%	-3.29%	-138.66%	-3.29%	-14.09%	-2.34%	Upgrade
FCF Yield	-0.34%	-6.71%	-193.87%	-4.41%	-12.72%	-	Upgrade
Buyback Yield / Dilution	-	-10978.80%	-0.01%	-0.02%	-	-	Upgrade

Source: S&P Global Market Intelligence. Standard template. Financial Sources.